WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells
2011

WSX1 Expression in Tumors Induces Immune Tolerance

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dibra Denada, Cutrera Jeffry, Xia Xueqing, Li Shulin

Primary Institution: MD Anderson Cancer Center

Hypothesis

WSX1 expression in tumors promotes immune tolerance and tumor growth independent of IL27 signaling.

Conclusion

The study found that WSX1 expression in tumors leads to T cell death and reduced production of the effector cytokine IFNγ, promoting tumor growth.

Supporting Evidence

  • WSX1 expression in tumor cells was shown to induce T cell death.
  • Reduced IFNγ production was observed in the presence of WSX1-positive tumors.
  • WSX1 expression promoted tumor growth in immune-competent mice.

Takeaway

When a certain protein called WSX1 is found in tumors, it can trick the immune system into not attacking the tumor, allowing it to grow bigger.

Methodology

The study used genetically modified tumor cells and various assays to assess tumor growth and immune cell interactions.

Potential Biases

Potential bias in the interpretation of results due to the specific tumor models used.

Limitations

The study primarily focused on specific tumor models and may not generalize to all cancer types.

Participant Demographics

Mice models were used, specifically C57Bl/6 and TCCR−/− mice.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0019072

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication